期刊文献+

美洛昔康联合甲氨蝶呤对类风湿关节炎临床症状和实验室指标的影响 被引量:12

Effects of meloxicam and methotrexate on clinical symptoms and laboratory indicators of rheumatoid arthritis
下载PDF
导出
摘要 目的探讨美洛昔康联合甲氨蝶呤对类风湿性关节炎临床症状和实验室指标的影响。方法选取130例类风湿性关节炎患者进行研究,将患者以随机数字表法分为两组,对照组65例,采用单纯甲氨蝶呤治疗;观察组65例,采用美洛昔康联合甲氨蝶呤;比较两组患者的治疗效果。结果观察组患者临床总有效率明显高于对照组(P <0. 05);治疗后两组患者各症状及实验室指标比较差异均有统计学意义(P <0. 05);两组不良反应情况比较差异无统计学意义(P> 0. 05)。结论以美洛昔康与甲氨蝶呤联合治疗方式对类风湿性关节炎患者实施治疗效果显著,有利于改善病情。 Objective To investigate the effects of meloxicam combined with methotrexate on clinical symptoms and laboratory indexes of rheumatoid arthritis.Methods A total of 130 patients with rheumatoid arthritis were selected for the study.The patients were divided into two groups by random number table method.The 65 patients in the control group were treated with methotrexate alone,and the other 65 patients in the observation group were treated with meloxicam combined with methotrexate.The therapeutic effects of the two groups were compared.Results The total clinical effective rate of the observation group was significantly higher than that of the control group (P<0.05).After treatment,there were significant differences in symptoms and laboratory indicators between the two groups (P<0.05),and no significant difference in adverse reactions between the two groups (P>0.05).Conclusion Meloxicam combined with methotrexate are effective in the treatment of patients with rheumatoid arthritis,which is conducive to improve the condition and symptoms.
作者 金都 梁一民 Jin Du;Liang Yimin(Department of Rheumatology and Immunology,Taizhou First People's Hospital,Taizhou 318020,China)
出处 《中国临床保健杂志》 CAS 2019年第3期359-361,共3页 Chinese Journal of Clinical Healthcare
基金 浙江省医药卫生科研基金项目(2017KY713)
关键词 关节炎 类风湿 甲氨蝶呤 美洛昔康 治疗结果 Arthritis,rheumatoid Methotrexate Meloxicam Treatment outcome
  • 相关文献

参考文献6

二级参考文献84

  • 1缪怡,胡朝英,钱柳,张冬青.类风湿性关节炎免疫学研究进展[J].上海交通大学学报(医学版),2011,31(7):1035-1040. 被引量:37
  • 2隋丽,赵晓刚,姚健,喜斌,胡晓晨.蒸气透皮法治疗类风湿关节炎57例疗效观察[J].黑龙江医学,2004,28(9):703-703. 被引量:5
  • 3张虹妍.药物穴位注射治疗类风湿关节炎26例临床观察[J].实用中医内科杂志,2004,18(5):456-456. 被引量:1
  • 4邓小玲,王英,谭小波,梁燕.类风湿关节炎患者心理状况的调查分析[J].护理学杂志(综合版),2006,21(3):54-55. 被引量:16
  • 5马宝东,陈岩松,陈雪,闫海屿.风湿止痛散外治活动期类风湿关节炎临床观察[J].中华中医药学刊,2007,25(6):1298-1299. 被引量:2
  • 6Sang KG,Teng GG,Patkar NM,et al.American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.Arthritis Rheum,2008,59:762-784.
  • 7van Vollenhoven RF.Treatment of rheumatoid arthritis:state of the art 2009.Nat Bey Rheumatol,2009,5:531-541.
  • 8Rantalaiho V,Korpela M,Hannonen P,et al.The good initial response to therapy with a combination of traditional diseasemodifying antirheumatic drugs is sustained over time:the elevenyear results of the Finnish rheumatoid arthritis combination therapy trial.Arthritis Rheum,2009,60:1222-1231.
  • 9Goekoop-Ruiterman YP,de Vries-Bouwstra JK,Allaart CF,et al.Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study):A randomized,controlled trial.Arthritis Rheum,2008,58 (2 Suppl):S126-135.
  • 10Sokka T,Envalds M,Pincus T.Treatment of rheumatoid arthritis:a global perspective on the use of antirheumatic drugs.Med Rheumatol,2008,18:228 -239.

共引文献256

同被引文献135

引证文献12

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部